Beautiful Virgin Islands

Tuesday, Oct 07, 2025

Covax signs agreement with Moderna for 500 million doses of anticovid vaccine

Covax signs agreement with Moderna for 500 million doses of anticovid vaccine

"We are excited to sign this new agreement with Moderna, which gives Covax participants access to another highly effective vaccine," said Seth Berkley.
The Covax program, which favors the equitable distribution of vaccines, signed an agreement with Moderna to acquire 500 million doses of its anticovid vaccine, the Vaccine Alliance (Gavi) announced on Monday.

"We are very pleased to sign this new agreement with Moderna, which gives Covax participants access to another highly effective vaccine," said Seth Berkley, Gavi's CEO, in a statement.

The first doses of this messenger RNA vaccine should be delivered in the fourth quarter of 2021, "with a total of 34 million available" this year and "up to 466 million doses in 2022, the note said.

The Moderna vaccine is generally given in two doses, although the new recommendations call for a single dose if the patient has recently had COVID.

The agreement also contains "options that eventually make it possible to obtain vaccine doses adapted to future variants," the Geneva-based organization said.

"Expanding and diversifying the portfolio has always been a key goal for Covax, and to remain flexible in the face of this ever-evolving pandemic - including the growing threat of new variants," Berkley said. This agreement with Moderna "is one more step in this direction," he said.

The World Health Organization (WHO) on Friday granted its emergency homologation to Moderna's vaccine, a prerequisite for it to be integrated into the Covax system, which it established together with Gavi, and Cepi (Coalition for Epidemic Preparedness Innovations).

The agreement is "an important step in our efforts to ensure that populations around the world have access to our COVID-19 vaccine," said Moderna chief Stéphane Bancel, acknowledging that "many countries have limited resources to access to vaccines".

In addition to Moderna, the WHO has already licensed the vaccine from Pfizer-BioNTech, the two AstraZeneca sera manufactured in India and South Korea, and the one from Johnson & Johnson.

So far, Covax, whose main supplier remains AstraZeneca, has distributed more than 49 million vaccines in 121 countries and territories.

The vaccine developed by Moderna, a pioneering startup in anticovid vaccines, has characteristics similar to that developed by Pfizer-BioNTech, with 94.1% efficacy.
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Three Scientists Awarded Nobel Prize in Medicine for Discovery of Immune Self-Tolerance Mechanism
OpenAI and AMD Forge Landmark AI-Chip Alliance with Equity Option
Munich Airport Reopens After Second Drone Shutdown
France Names New Government Amid Political Crisis
Trump Stands Firm in Shutdown Showdown and Declares War on Drug Cartels — Turning Crisis into Opportunity
Surge of U.S. Billionaires Transforms London’s Peninsula Apartments into Ultra-Luxury Stronghold
Pro Europe and Anti-War Babiš Poised to Return to Power After Czech Parliamentary Vote
Jeff Bezos Calls AI Surge a ‘Good’ Bubble, Urges Focus on Lasting Innovation
Japan’s Ruling Party Chooses Sanae Takaichi, Clearing Path to First Female Prime Minister
Sean ‘Diddy’ Combs Sentenced to Fifty Months in Prison Following Prostitution Conviction
Taylor Swift’s ‘Showgirl’ Launch Extends Billion-Dollar Empire
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
×